BCTX BRIACELL THERAP

NASDAQ
$4.28

BRIACELL THERAP (BCTX) is expected to report earnings on October 6, 2026, before the market open.

BRIACELL THERAP Reported Earnings
Tuesday, June 9, 2026 · 12:00 AM ET
Earnings Date
Oct 6
Tuesday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BRIACELL THERAP

BriaCell Therapeutics Corp. is an immuno-oncology focused biotechnology company. It developed a patented whole-cell vaccine, cancer immunotherapy technology called the BriaVax vaccine for cancer. The company's technology consists of Bria-IMT(TM), Bria-OTS(TM) and BriaDx(TM) which are in clinical stage. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Charts powered in part by Lightweight Charts™ by TradingView.